This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Andrew Pavia
andrewpaviamd.bsky.social
did:plc:k4m3cdszszbluivmdqatjvgj
@helenbranswell.bsky.social reports on the odd logic and questioning by the handpicked ACIP members about what should have been and easy vote - adding a second effective RSV monoclonal. CDC vaccine advisers recommend Merck’s RSV therapy for babies https://www.statnews.com/2025/06/26/cdc-acip-merck-rsv-monoclonal-antibody-enflonsia/ via @statnews.com
2025-06-26T16:57:41.246Z